Table 2 TROP-2 expression, AR expression, sTILs and SMI.

From: Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer

Variable

Statistic

Total

TROP-2 score

N

589

Mean

88.0

Median

70.0

Range

(0.0; 300.0)

TROP-2 categorical

Low H-score < 100

n (%)

343 (58.2%)

Medium H-score 100–200

149 (25.3%)

High H-score 201–300

97 (16.50%)

NA

96

AR percentage

N

602

Mean

14.9

Median

0.0

Range

(0.0; 100.0)

AR (1% cutoff)

Negative

n (%)

412 (68.1%)

Positive

193 (31.9%)

NA

80

AR (10% cutoff)

Negative

n (%)

457 (75.5%)

Positive

148 (24.5%)

NA

 

sTILs score

N

606

Mean

26.5

Median

20.0

Range

(0.0; 96.0)

sTILs categorical

Low (> 30)

n (%)

381 (62.9%)

Medium (30–49)

109 (18.0%)

High (> 50)

116 (19.1%)

NA

79

SMI

N

457

Mean

19.3

Median

16.8

Range

(0.0; 128.5)

SMI (binary)

 < Median (16.8)

n (%)

229 (50.1%)

 ≥ Median (16.8)

228 (49. 9%)

NA

228

  1. AR androgen receptor, sTILs stromal tumor-infiltrating lymphocytes, SMI standardized mitotic index, NA not available.
Back to article page